Castellum, Inc. Announces $950,000 New Revolving Credit Facility from Live Oak Bank

3 years ago

Castellum, Inc. Announces $950,000 New Revolving Credit Facility from Live Oak Bank Castellum, Inc. (OTC: ONOV) announces that it has…

INmune Bio, Inc. Highlights INKmune™ Data Featured in NK Cells in Solid Tumors Workshop at Innate Killer Summit

3 years ago

INKmune™, unlike IL15 and other NK-activating cytokines, upregulates all mitochondrial survival proteins and more than 40 nutrient receptors on the…

Allied Corp Commends Colombian Government for Announcing the Final Approval of the Regulations for the Export of Cannabis From Colombia

3 years ago

KELOWNA, British Columbia, April 04, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to…

Dyadic International to Present at Upcoming Scientific Medical Meetings

3 years ago

JUPITER, Fla., April 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology…

Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference

3 years ago

Company announcement – No. 11 / 2022 Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference Copenhagen, DK and Boston, MA,…

Vaxcyte Doses First Participants in Phase 2 Portion of Ongoing VAX-24 Phase 1/2 Clinical Proof-of-Concept Study in Adults

3 years ago

-- Following Prespecified Review of Phase 1 Safety and Tolerability Data, Independent Data Monitoring Committee Recommends Study Proceed as Planned…

eFFECTOR Therapeutics Announces Transition in Clinical Leadership

3 years ago

Premal Patel, M.D., Ph.D., chief medical officer, has resigned to pursue a new career opportunity Robert Sikorski, M.D., Ph.D., to…

eGenesis Appoints Eliezer Katz, M.D., FACS, as Chief Medical Officer

3 years ago

CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs and cells, today…

Journey Medical Corporation to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities

3 years ago

SCOTTSDALE, Ariz., April 04, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (NADSAQ: DERM), a commercial-stage pharmaceutical company that…

CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference

3 years ago

BERKELEY HEIGHTS, N.J., April 04, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…